|
Delayed
Nasdaq Stockholm
08:41:47 20/11/2026 GMT
|
5-day change | 1st Jan Change | ||
| 7.200 SEK | -0.69% |
|
0.00% | -46.67% |
| 11-12 | Vivesto narrows loss | FW |
| 11-12 | Vivesto AB Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2026 | CI |
| Market Cap | 80.27M 7.87M 7.17M 6.64M 6.01M 11.27M 735M 11.79M 31.84M 397M 29.54M 28.92M 1.26B | P/E 2026 * |
-2.59x | P/E 2027 * | -2.06x |
|---|---|---|---|---|---|
| Enterprise Value | 69.27M 6.79M 6.19M 5.73M 5.18M 9.72M 635M 10.18M 27.48M 343M 25.49M 24.96M 1.09B | EV / Sales 2026 * |
-
| EV / Sales 2027 * | - |
| Free-Float |
52.67% | Yield 2026 * |
-
| Yield 2027 * | - |
Nasdaq StockholmSEK
| Markets | Quality | ||
|---|---|---|---|
Nasdaq Stockholm
| VIVE | Delayed | |
| OMA | Delayed | ||
| 0N4A | Real-time | ||
| OASMs | Real-time | ||
| OMA | Delayed |
Last Transcript: Vivesto AB
| 1 day | +1.54% | ||
| 1 week | -3.33% | ||
| Current month | -6.45% | ||
| 1 month | +1.26% | ||
| 3 months | -19.35% | ||
| 6 months | -13.69% | ||
| Current year | -46.30% |
| 1 week | 7 | 7.5 | |
| 1 month | 6.74 | 8.09 | |
| Current year | 6.5 | 19.5 | |
| 1 year | 6.5 | 23 | |
| 3 years | 6.5 | 90.6 | |
| 5 years | 6.5 | 302.9 | |
| 10 years | 6.5 | 1,670 |
| Manager | Title | Age | Since |
|---|---|---|---|
Erik Kinnman
CEO | Chief Executive Officer | 68 | 22/01/2023 |
Björn Svanström
DFI | Director of Finance/CFO | 55 | 30/06/2026 |
| Chief Tech/Sci/R&D Officer | 39 | 31/12/2022 |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | 46 | 24/05/2022 | |
Hege Hellstrom
BRD | Director/Board Member | 61 | 25/09/2019 |
Pål Ryfors
BRD | Director/Board Member | 43 | 24/05/2022 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 25/03/22 | Buy | Chief Executive Officer | 12,200 | 0.0027% | ||
| 24/03/22 | Others | Chairman | 120,000 | 0.0268% | ||
| 20/12/21 | Free | Chief Executive Officer | 2,250,000 | 0.5018% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +1.54% | -3.33% | -69.41% | -62.59% | 7.87M | ||
| -2.29% | -5.34% | +28.73% | +128.34% | 1,204B | ||
| -2.04% | -5.78% | +31.91% | +78.34% | 643B | ||
| -0.86% | -3.71% | +21.74% | +105.02% | 501B | ||
| +0.29% | -1.80% | +28.69% | +68.01% | 378B | ||
| -3.61% | -9.62% | +39.73% | +30.53% | 327B | ||
| +0.80% | -5.20% | +24.48% | +51.30% | 285B | ||
| +0.65% | -4.49% | -2.15% | +29.67% | 270B | ||
| -1.14% | -6.05% | +28.16% | +65.35% | 237B | ||
| -1.45% | -0.85% | +30.03% | +120.72% | 207B | ||
| Average | -0.84% | -4.29% | +16.19% | +61.47% | 405B | |
| Weighted average by Cap. | -1.43% | -4.71% | +26.93% | +87.91% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | - | - |
| Net income | -28M -2.75M -2.5M -2.32M -2.1M -3.93M -257M -4.11M -11.11M -139M -10.3M -10.09M -439M | -39M -3.83M -3.49M -3.23M -2.92M -5.47M -357M -5.73M -15.47M -193M -14.35M -14.05M -612M |
| Net Debt | -11M -1.08M -983K -910K -823K -1.54M -101M -1.62M -4.36M -54.45M -4.05M -3.96M -172M | -20M -1.96M -1.79M -1.65M -1.5M -2.81M -183M -2.94M -7.93M -99.01M -7.36M -7.21M -314M |
Employees
4
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 20/11/26 | SEK 7.200 | -0.69% | 408 |
| 19/11/26 | SEK 7.250 | +1.54% | 2,752 |
| 18/11/26 | SEK 7.140 | -1.24% | 7,252 |
| 17/11/26 | SEK 7.230 | +0.98% | 9,122 |
| 16/11/26 | SEK 7.160 | -0.56% | 1,536 |
Annual profits - Rate of surprise
- Stock Market
- Stocks
- VIVE Stock
Select your edition
All financial news and data tailored to specific country editions
















